Axonics Past Earnings Performance

Past criteria checks 0/6

Axonics has been growing earnings at an average annual rate of 14.1%, while the Medical Equipment industry saw earnings growing at 0.5% annually. Revenues have been growing at an average rate of 48.1% per year.

Key information

14.1%

Earnings growth rate

30.4%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate48.1%
Return on equity-2.5%
Net Margin-4.1%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Axonics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:0I3 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 24387-1625238
31 Dec 23366-623535
30 Sep 23343-1222333
30 Jun 23320-3221333
31 Mar 23296-4620831
31 Dec 22274-6019634
30 Sep 22241-7618136
30 Jun 22217-7716837
31 Mar 22194-8015139
31 Dec 21180-8013637
30 Sep 21162-7612135
30 Jun 21150-6810934
31 Mar 21120-639532
31 Dec 20112-559229
30 Sep 2087-668927
30 Jun 2053-828724
31 Mar 2039-818223
31 Dec 1914-806820
30 Sep 194-675119
30 Jun 193-493418
31 Mar 192-392119
31 Dec 181-321319
30 Sep 180-281018
30 Jun 180-25717
31 Mar 180-20614
31 Dec 170-18612

Quality Earnings: 0I3 is currently unprofitable.

Growing Profit Margin: 0I3 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0I3 is unprofitable, but has reduced losses over the past 5 years at a rate of 14.1% per year.

Accelerating Growth: Unable to compare 0I3's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0I3 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-6.1%).


Return on Equity

High ROE: 0I3 has a negative Return on Equity (-2.54%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.